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Commentary
After extensive debate and preparation, the 
new European chemicals legislation, REACH 
(Registration, Evaluation and Authorisation of 
Chemicals), was finally adopted in December 
2006 (European Commission 2006; includes 
all REACH annexes described herein). The new 
legislation aims to improve risk management of 
industrial chemicals produced in or imported 
into Europe. Risk management has to be based 
on a hazard assessment and, if possible, a risk 
assessment, and the lack of data on the hazards 
(toxicity and ecotoxicity) of the vast major­
ity of general industrial chemicals was a major 
justification for the initiative by the European 
Commission that ultimately led to the new 
legis  lation (Allanou et al. 1999; National 
Research Council 1984; Roe et al. 1997). 
REACH came into force on 1 June 2007, 
and the legislation will be implemented gradu­
ally until 31 May 2018. Registration of test 
data shall be completed before 30 November 
2010 for substances produced or imported in 
quantities of ≥ 1,000 metric tons/year, before 
31 May 2013 for substances produced or 
imported in quantities of ≥ 100 metric tons/
year, and before 31 May 2018 for substances 
produced or imported in quantities of ≥ 1 met­
ric tons/year. (The yearly tonnage refers to met­
ric tons per manufacturer or importer, not to 
the total volume manufactured or imported.)
The purpose of this commentary is to ana­
lyze how much data will in fact be generated 
within REACH and to relate this to the needs 
of hazard assessment. We first summarize 
the data requirements for different tonnage 
bands, and then relate these requirements to 
the requirements of hazard assessment. We 
conclude by proposing improvements in the 
data requirements and related aspects of the 
REACH system.
Data Requirements for the 
Different Tonnage Bands
According to REACH, chemicals produced or 
imported in quantities of ≥ 1 metric tons/year 
(per manufacturer/importer) must be registered 
in a central database. Unregistered substances 
may not be manufactured or imported into the 
European Union in amounts > 1 metric ton/
year. In addition to the registration, a tech­
nical dossier containing data from whatever 
tests are mandatory for the substance in ques­
tion shall be submitted. The data requirements 
are primarily determined by the produced or 
imported volume. Substances are divided into 
five tonnage bands: < 1, ≥ 1, ≥ 10, ≥ 100, and 
≥ 1,000 metric tons/year, per manufacturer/
importer. In what follows, we summarize the 
data requirements in each of these tonnage 
bands. The data requirements accumulate over 
the tonnage bands, such that for substances 
produced or imported in quantities of ≥ 10 
metric tons/year, the data requirements for sub­
stances produced or imported in quantities of 
≥ 1 metric tons/year are also applicable, and so 
on. The data requirements are also summarized 
in Tables 1–3.
Substances produced or imported in quan­
tities of < 1 metric ton/year. Substances that 
are produced or imported in quantities of 
< 1 metric ton/year by any single manufac­
turer or importer are not covered by REACH. 
Obviously, highly toxic or ecotoxic substances 
produced or imported in these quantities may 
cause more problems than a less toxic substance 
produced or imported in much larger volumes. 
The exclusion from REACH of substances in 
this tonnage band must be seen as one of the 
compromises that were made in order to facili­
tate implementation of the legislation.
Substances manufactured or imported in 
quantities of ≥ 1 metric tons/year. The test 
requirements for the chemicals in this ton­
nage band are quite complex because these 
substances are divided into three different 
categories, as specified in REACH annex VII. 
The criteria are specified in annex III:  
1) Unprioritized phase­in substances are 
substances that were also regulated in the 
  previous legislation and do not qualify for 
category 2. 
2) Prioritized phase­in substances are sub­
stances that were regulated in the previous 
legislation and in addition fall into one of the 
following two subcategories (as specified in 
the REACH annex III): a) Substances that 
are predicted {by the application of (quanti­
tative) structure–activity relationships [(Q)
SAR] or other evidence} to be likely to meet 
the criteria for category 1 or 2 classification 
for carcinogenicity, mutagenicity, or repro­
ductive toxicity [according to the European 
classification and labeling directive EEC 
67/548; European Economic Community 
(EEC) 1967], or the criteria for persistent, 
bioaccumulating, and toxic substances (PBT), 
or the criteria for very persistent and very bio­
accumulating (vPvB) substances (according to 
annex XIII of REACH). b) Substances that 
both i) have dispersive or diffuse (consumer) 
use(s) and ii) are predicted [by the application 
of (Q)SAR or other evidence] to be likely to 
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meet the classification criteria for any human 
health or environmental effects end points 
under the European classification and labeling 
directive (EEC 1967). 
3) Non­phase­in substances are substances 
introduced on the market subsequent to the 
REACH implementation.
Only very limited information on physico­
chemical properties is required for substances 
in all these three categories: state at 20°C and 
101.3 kPa, melting/freezing point, boiling 
point, relative density, vapor pressure, surface 
tension, water solubility, octanol/water par­
tition coefficient, flash point, flammability, 
explosive properties, self­ignition temperature, 
oxidizing properties, and granulometry.
For unprioritized phase­in substances, no 
further data are required, and in particular no 
toxicity testing is required. For non­phase­in 
and prioritized phase­in substances, the fol­
lowing additional test requirements apply: 
acute (oral) toxicity, in vivo skin sensitiza­
tion, one in vitro test for gene mutations in 
bacteria (further mutagenicity tests can be 
required in case of a positive result), acute 
toxicity to algae and Daphnia, and biotic deg­
radation (ready biodegradability) (REACH 
annex VII). [According to REACH, results 
from in vitro testing of eye and skin irritation 
are also required for substances produced or 
imported in quantities of ≥ 1 metric tons/year. 
However, no such standardized in vitro tests 
are currently available in the Organisation for 
Economic Co­operation and Development 
(OECD) test guidelines.]
The actual outcome of the test require­
ments for the chemicals in this tonnage band 
will thus depend on how the prioritization 
criteria are applied. The (Q)SAR models and 
other methods that will be used to generate 
data for prioritization purposes have not been 
defined. A large degree of flexibility is fore­
seen, and all decisions will be made in col­
laboration with the industry. According to 
the REACH guideline, 
The process of (Q)SAR acceptance under REACH 
will involve initial acceptance by industry and sub­
sequent evaluation by the authorities, on a case­
by­case basis. It is not foreseen that there will be a 
formal adoption process, in the same way that test 
methods are currently adopted in the EU [European 
Union] and OECD. In other words, it is not fore­
seen that there will be an official, legally binding list 
of (Q)SAR methods. With reference to the accep­
tance criteria in REACH annex XI, it is stated that 
“the Agency in collaboration with the Commission, 
Member States and interested parties shall develop 
and provide guidance in assessing which (Q)SARs 
will meet these conditions and provide examples.” 
(European Chemicals Agency 2008)
Because the criteria that will be used to 
trigger toxicity and ecotoxicity testing in 
substances in this tonnage band have not 
yet been decided, it is not possible to foresee 
how many of these substances will be tested. 
The outcome of the test requirements for the 
“phase­in” low­volume chemicals can in prin­
ciple be that all or none are tested.
Substances manufactured or imported in 
quantities of ≥ 10 metric tons/year. For sub­
stances produced or imported in quantities 
of ≥ 10 metric tons per year and per manu­
facturer or importer, the following additional 
data are required: in vivo skin and eye irrita­
tion, acute mammalian toxicity (second route 
in addition to oral route), acute toxicity to 
fish and microorganisms (activated sludge res­
piration inhibition), data on hydrolysis, an 
adsorption/desorption screening study, and 
an in vitro cytogenicity test using mamma­
lian cells or an in vitro micronucleus test. If 
the mutagenicity tests performed are negative, 
then an in vitro gene mutation study using 
mammalian cells is also required. If a posi­
tive result is obtained in any of the tests, then 
further in vivo mutagenicity studies “shall be 
considered” (REACH annex VIII). In addition 
to these tests, a 28­day repeated­dose mamma­
lian toxicity test and screening for reproductive 
toxicity can be required, but these tests are not 
mandatory and testing can be waived based 
on, for instance, the magnitude and nature of 
human exposures (REACH annex VIII).
The extent to which the 28­day study is 
waived is important for hazard assessment. If 
data from a 28­day study are available, then 
a hazard assessment according to the classifi­
cation criteria for subchronic toxicity can be 
made. Without these data, classifications are 
possible only for acute responses (EEC 1967).
Substances manufactured or imported 
in quantities of ≥ 100 metric tons/year and 
≥ 1,000 metric tons/year. The ≥ 100 metric 
tonnage band includes data requirements about 
fate and behavior (bioaccumulation, simula­
tion testing, and identification of degradation 
products), long­term toxicity to fish (OECD 
Table 1. REACH data requirements: ecotoxicity. 
Metric tons/year
Category  < 1  ≥ 1  ≥ 10  ≥ 100  ≥ 1,000
Long-term or reproductive toxicity: birds No No No No (Yes?)
Long-term toxicity sediment: organisms No No No No (Yes?)
Long-term toxicity: plants and terrestrial organisms No No No No (Yes?)
Short-term toxicity: plants and terrestrial organisms No No No (Yes?) (Yes?)
Long-term toxicity: fish and Daphniaa No No No (Yes?) (Yes?)
Activated sludge respiration inhibition No No Yes Yes Yes
Short-term toxicity: fisha No No Yes Yes Yes
Short-term toxicity: algaea No (No?) Yes Yes Yes
Short-term toxicity: Daphniaa No (No?) Yes Yes Yes
(No?): testing can be triggered according to certain criteria; (Yes?): testing can be waived according to certain criteria.
aThe test has a direct use for classification purposes.  
Table 3. REACH data requirements: toxicity.
Metric tons/year
Category  < 1  ≥ 1  ≥ 10  ≥ 100  ≥ 1,000
Chronic toxicity and carcinogenicitya No No No No (Yes?)
Reproductive toxicity (one generation)a No No No (Yes?) (Yes?)
Subchronic (90 days)a No No No (Yes?) (Yes?)
Screening for reproductive toxicity No No (Yes?) (Yes?) (Yes?)
Subacute (28 days)a No No (Yes?) Yes Yes
Acute toxicity second routea No No Yes Yes Yes
Skin + eye irritation (in vivo)a No No Yes Yes Yes
Additional mutagenicity tests (in vitro) No No Yes Yes Yes
Acute toxicity oral routea No (No?) Yes Yes Yes
Mutagenicity (in vitro) No (No?) Yes Yes Yes
Skin sensitizationa No (No?) Yes Yes Yes
Skin + eye irritation (in vitro) No (No?) Yes Yes Yes
(No?): testing can be triggered according to certain criteria; (Yes?): testing can be waived according to certain criteria.
aThe test has a direct use for classification purposes.
Table 2. REACH data requirements: fate and behavior.
Metric tons/year
Category  < 1  ≥ 1  ≥ 10  ≥ 100  ≥ 1,000
Bioaccumulation in fisha No No No (Yes?) (Yes?)
Identification of degradation products No No No (Yes?) (Yes?)
Simulation testinga No No No (Yes?) (Yes?)
Hydrolysis No No Yes Yes Yes
Adsorption/desorption screening No No Yes Yes Yes
Biotic degradation (ready   biodegradation)a No (No?) Yes Yes Yes
(No?): testing can be triggered according to certain criteria; (Yes?): testing can be waived according to certain criteria.
aThe test has a direct use for classification purposes.Rudén and Hansson
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test guidelines 210, 212, or 215; OECD 1992, 
1998, 2000), and Daphnia, short­term toxicity 
to terrestrial organisms and plants, subchronic 
toxicity to mammals (90 days of exposure), 
developmental toxicity (OECD test guideline 
414; OECD 2001a), and a two­generation 
reproductive toxicity study (OECD test guide­
line 416; OECD 2001b) (REACH annex IX). 
For the ≥ 1,000 metric tonnage band, addi­
tional (long­term) effect data on sediment liv­
ing organisms, terrestrial organisms, and plants 
can be required, as well as additional data on 
bird reproduction and a carcinogenicity study 
(REACH annex X).
In the prefaces to each of these annexes, it is 
clarified that at this tonnage band “the registrant 
must submit a proposal and a time schedule for 
fulfilling the information requirements.” The 
test requirements are presented in two separate 
columns, and column 2 lists the “rules accord­
ing to which the registrant may propose to omit 
the required standard information, replace it by 
other information, provide it at a later stage or 
adapt it in another way.” Furthermore, accord­
ing to the preface, the registrant “may propose 
to adapt the required standard information set 
out in column 1 of this annex according to the 
general rules contained in annex XI.” Annex 
XI lists several possibilities to waive testing—
for example, based on the exposure scenarios, 
existing test data, read­across approaches, and   
(Q)SAR or in vitro data, or if there is “suf­
ficient weight of evidence from several inde­
pendent sources of information leading to the   
assumption/conclusion that a substance has or 
has not a particular dangerous property, while 
the information from each single source alone 
is regarded insufficient to support this notion.” 
The major advantage of these rules is that they 
contribute to avoiding unnecessary testing and 
introduce flexibility into the system. A possible 
disadvantage is that the implementation of the 
test requirements and the outcome of the legis­
lation become less predictable.
Testing in these tonnage bands will thus be 
proposed by the industry, and the proposal has 
to be approved by the authority. This applies to 
all the test requirements in annexes IX and X. 
Hence, for all the additional tests introduced in 
the two highest tonnage bands, the actual test­
ing will be determined on a case­by­case basis, 
and the outcome of test requirements in the 
high­tonnage bands is thus dependent on how 
this process is implemented.
How Much Hazard Assessment Is 
Possible with the REACH Data?
The purpose of REACH is to generate data 
on the toxicity and ecotoxicity of industrial 
chemicals in order to improve risk assessment 
and risk management. Therefore, it is impor­
tant to analyze the extent to which the data 
required by REACH suffice to make a haz­
ard assessment. Of course, ideally a hazard 
assessment should be based on extensive data 
that go beyond these data requirements. 
However, minimal requirements on data, to 
make a hazard assessment at all meaningful, 
have been laid down in the European directive 
for classification and labeling (EEC 1967). 
That directive does not specify data require­
ments; it provides the criteria by which avail­
able data should be assessed and specifies the 
corresponding hazard classification categories 
and the warning labeling that applies to each 
classification. Hence, whereas REACH lays 
down the data requirements, the classification 
and labeling directive regulates how to classify 
substances according to these data, provide the 
appropriate hazard information, and convey it 
to the users of chemicals with the aim to pro­
mote safe handling of the substances. Besides 
the classification criteria, the classification and 
labeling directive also specifies standardized 
test methods for different end points. For 
several end points the directive refers directly 
or indirectly to a corresponding OECD test 
guideline. For some end points the preferred 
methods are not clearly specified (e.g., for 
mutagenicity testing). However, results from 
standardized tests—for example, performed 
according to OECD test guidelines—are read­
ily accepted, and in practice often required, for 
classification purposes.
The important connection between 
REACH and the classification and labeling 
directive makes it important to compare the 
data required by REACH with the data that 
are required for hazard assessment of different 
end points according to the classification and 
labeling directive. The analyses reported below 
are based on the criteria as specified according 
to the European classification and labeling 
directive (EEC 1967) and its amendments. 
These criteria will be in force until the year 
2015 in parallel with the new globally har­
monized system for classification and warning 
labeling that will then replace this directive 
(European Commission 2008).
Acute toxicity. For substances in the 1–10 
metric tonnage band that will be categorized 
either as non­phase­in (i.e., substances intro­
duced on the market after REACH went into 
force) or as prioritized phase­in substances, the 
data required in REACH will enable appli­
cation of the classification criteria for acute 
(mammalian) toxicity. For the phase­in sub­
stances that are not prioritized, no data that 
can be used for toxicity or ecotoxicity classifi­
cation will be required by REACH. For sub­
stances produced or imported in the 10 metric 
tonnage band, the data required in REACH 
will be enough to apply the classification 
criteria for skin and eye irritation and acute 
(mammalian) toxicity. This is one of the most 
important open issues in the implementation 
of REACH, because classification according 
to irritation and acute toxicity is fundamental 
for the safe handling of chemicals, especially in 
the workplace.
Subacute toxicity. For substances pro­
duced or imported in quantities of < 10 met­
ric tons/year, the data required by REACH 
will not be sufficient for classification 
according to the criteria for subacute toxic­
ity (European Commission 2001). For sub­
stances produced or imported in quantities of 
10–100 metric tons/year, the data required in 
REACH may suffice to apply these classifica­
tion criteria. However, this is among the data 
requirements that can be waived. Decisions 
yet to be made will thus determine to what 
extent the requirement of the 28­day study 
will be implemented or waived. For sub­
stances produced or imported in quantities of 
≥ 100 metric tons/year, data from the 28­day 
study will be mandatory.
Mutagenicity. REACH introduces a tiered 
approach to mutagenicity testing, which 
means that the ultimate test requirements are 
determined based on the results from initial 
testing in a stepwise procedure. According 
to the classification and labeling directive, 
classification as a mutagenic compound can 
be based on either human or animal data. 
Human data are required for a category 1 
classification (substances known to be muta­
genic to humans), but for a classification as 
a category 2 or 3 mutagen, animal data are 
sufficient. The criteria are applicable only to 
in vivo data, but apart from that no further 
specification on appropriate methods is pro­
vided. This should be determined on a case­
by­case basis (European Commission 2001). 
Hence, a hazard assessment will be possible 
only to the extent that positive results are 
obtained by in vitro tests initially required 
by REACH and, as a consequence, further 
in vivo testing is proposed and performed.
Carcinogenicity. According to the classifi­
cation and labeling directive, classification as a 
carcinogen can be based on either human or 
animal data. Human data are required for a cat­
egory 1 classification (substances known to be 
carcinogenic to humans), but for a classification 
as a category 2 or 3 carcinogen, animal data 
are sufficient. In practice, this usually requires 
data obtained from a standardized long­term 
carcinogenicity study (European Commission 
2001). For substances produced or imported in 
quantities of < 1,000 metric tons/year, the data 
required in REACH will not suffice to apply 
the classification criteria for carcinogenicity. 
For substances produced or imported in quan­
tities of ≥ 1,000 metric tons/year, such data can 
be required within REACH, but this require­
ment can also be waived. Again, the extent to 
which this requirement will be implemented 
depends on decisions that are yet to be made 
(see also Scheringer et al. 2006).
Reproductive toxicity. The test methods 
applicable to the classification criteria for REACH is but the first step
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reproductive toxicity are not specified in the 
classification and labeling directive (European 
Commission 2001). However, in practice, 
the prenatal developmental toxicity study 
(OECD test guideline 414; OECD 2001a) is 
needed to apply the criteria for developmental 
toxicity, and the two­generation reproduc­
tion toxicity study (OECD test guideline 416; 
OECD 2001b) is needed for classification 
of effects on fertility (Ohlsson A, Swedish 
Chemicals Agency, personal communication). 
The reproductive toxicity screening test that 
may be required by REACH for chemicals 
in the ≥ 10 metric tonnage bands is thus usu­
ally not sufficient for classification. A hazard 
assessment for reproductive toxicity according 
to the classification and labeling criteria will 
hence be possible only with the REACH data 
required for substances in the ≥ 100 metric 
tonnage bands and only to the extent that 
these test requirements are proposed and 
approved by the industry and the authority.
Ecotoxicity. Classification of aquatic toxic­
ity requires, at a minimum, short­term tox­
icity data from fish, algae, or Daphnia. For 
classification of long­term effects, these data 
must be used in combination with degrada­
tion data (ready biodegradability test), data 
on lipophilicity (log P), or data on bioconcen­
tration (BCF) (European Commission 2001). 
A hazard classification for aquatic toxicity will 
thus be possible for substances in the ≥ 10 
metric tonnage bands. Whether this will also 
be possible for the ≥ 1 metric tonnage band 
depends on the outcome of the REACH pri­
oritization procedures as described above.
PBT and vPvB. The criteria for identify­
ing PBT and vPvB substances are specified 
in REACH annex XIII and not in the clas­
sification and labeling directive. Application 
of these criteria will be possible only for sub­
stances in the ≥ 100 metric tonnage bands 
and only to the extent that the tests in the 
high­tonnage bands will be proposed and 
approved by industry and the authority. (The 
criteria are based on BCF, long­term toxic­
ity, or ecotoxicity tests and the half­lives of 
the substances in different compartments. 
To determine half­lives, simulation testing is 
needed.)
Hence, for each of these end points, it is 
still undetermined for which substances the 
data minimally necessary for a hazard assess­
ment will be required in the REACH system.
REACH Was the First Step—
What Are the Next Ones?
REACH has provided a structure in which 
well­informed chemicals risk management 
can be developed. In particular, it creates a 
legislative and regulatory framework in which 
the procurement of data for reasonably reli­
able hazard assessments is possible. But on the 
other hand, as we have shown above, it does 
not require the creation of such data for all 
substances for which it is needed, and there 
are important open issues concerning what 
data will actually be required.
This is not surprising because the defi­
ciencies in the previous system of chemicals 
regulation were so large that it would be unre­
alistic to believe that they could be solved in 
one single reform. It is expected that there is 
still room for improvement, and the legisla­
tion stipulates that the European Commission 
should, every 5 years, publish a general report 
on the experience acquired with the operation 
of the regulation. Furthermore, the REACH 
process has triggered extensive discussions 
about what types of testing and how much 
testing are indeed necessary to characterize 
hazards and, even more important, to ulti­
mately make science­based risk decisions. 
This discussion includes developing novel 
approaches to generating relevant information 
and principles on how to combine different 
tests into integrated test systems and how to 
manage remaining uncertainties and lack of 
data (e.g., Schaafsma et al. 2009).
Conclusion
We propose six improvements of the legisla­
tion that should be important future steps in 
the development of REACH. 
a) Clarify prioritization and waiving cri­
teria. The open issues concerning prioritiza­
tion and waiving practices need to be solved. 
As much as possible, they should be solved in 
a way that ensures the availability of the data 
minimally required to make hazard assess­
ments according to the classification and 
labeling directive (EEC 1967) for as many 
substances and end points as possible. The 
most important of these open issues concerns 
the prioritization of phase­in substances. For 
the prioritized phase­in substances, the most 
basic end points for an elementary assessment 
of toxicity and ecotoxicity will be covered, but 
for the nonprioritized substances REACH 
will not provide data for a meaningful hazard 
assessment of any end point.
b) Increase data requirements. Even if a 
substantial number of chemicals in the lowest 
tonnage band will be prioritized, and con­
sequently tested according to the REACH 
requirements, many substances produced or 
imported in quantities of < 10 metric tons/
year will still lack the data necessary for a 
meaningful hazard assessment and classifica­
tion according to the classification and label­
ing directive. It is clearly not in accordance 
with the objective of REACH to “ensure a 
high level of protection of human health and 
the environment” (European Commission 
2006) to allow a large number of substances to 
be continuously put on the market and used 
when the minimal data required to assess their 
hazardous properties and classify and label 
them are not available. In our view, a deci­
sion should be made as soon as possible that 
after the last time limit for data requirements 
that has already been decided (year 2018), 
data requirements similar to those currently 
required for substances produced or imported 
in quantities of ≥ 10 metric tons/year will be 
introduced for all substances produced or 
imported in quantities of 1–10 metric tons 
yearly. Only then are we approaching a situa­
tion when the principle “no data, no market” 
can be said to have been realized. At the same 
time, a thorough evaluation needs to be made 
of the exclusion of substances produced or 
imported in quantities of < 1 metric ton/year 
from the legislation, and ways to include at 
least some of these substances into the system 
should be considered. These efforts should 
be combined with the work to develop new 
approaches to priority setting, data generation, 
and management of remaining uncertainties.
c) Develop the tests and approaches needed 
to satisfy the information requirements. Before 
REACH went into force, it was estimated 
that 30,000 substances would be registered 
in the legislation. With the preregistration 
now completed, it includes some 145,000 
substance—about five times as many as 
expected. To design appropriate test require­
ments for such a large and diverse group of 
substances in a resource­efficient and scien­
tifically robust way is a difficult undertaking. 
The REACH process has triggered extensive 
discussions about how testing should effec­
tively be performed in the regulatory con­
text (e.g., Schaafsma et al. 2009; Scheringer 
et al. 2006; Rudén and Hansson 2007). How 
should chemicals be prioritized for testing? 
How extensive testing should be required? 
What (types of) tests should be included at 
different tiers? There is an urgent need for 
test systems that can fill the enormous data 
gap for insufficiently tested substances as 
efficiently as possible. Such a strategy must 
take into account the limitations in economic 
resources and testing capacity, and it must 
consider animal welfare and the aim to refine, 
reduce, and replace animal tests in regulatory 
toxicology. Furthermore, there is a desire to 
continuously incorporate novel toxicologic 
knowledge. A process to improve regulatory 
testing and risk assessment must therefore 
include new approaches and nontest meth­
ods [e.g., (Q)SAR, grouping, and read­across 
methods], development and standardization 
of novel test methods, and the determination 
of criteria and principles for risk assessment 
that can cope with new types of extrapola­
tions and uncertainties.
d) Promote substitution of high­risk 
chemi  cals. To manage chemical risks, we need 
to refrain from using chemicals in ways that 
give rise to unacceptable risks. To avoid this, 
we need to substitute high­risk substances with Rudén and Hansson
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less risky alternatives as much as possible. In 
REACH the most hazardous substances (“sub­
stances of very high concern”) are identified as 
those that are classified as carcinogenic, toxic 
to reproduction or mutagenic in category 1 or 
2, PBT or vPvB, or endocrine disrupting or 
give rise to an “equivalent level of concern” 
(REACH article 57). Such substances are can­
didates for inclusion in the list of substances 
subject to authorization (REACH annex XIV). 
However, as we have shown above, the REACH 
data requirements are in general insufficient for 
identifying chemicals with these properties. So 
far, fewer than 20 substances have been identi­
fied as substances of very high concern within 
REACH (see the European Chemicals Agency 
2009), possibly because the legislation only 
recently came into force, but concerns have 
been raised that the regulatory process of iden­
tifying substances of very high concern will be 
slow and bureaucratic [see, e.g., the Substitute 
It Now (SIN) Reporter; International Chemical 
Secretariat 2009]. To achieve the goals of 
REACH, it is essential to develop an efficient 
process for identifying substances of very high 
concern and making the appropriate risk man­
agement decisions for these compounds.
e) Acknowledge uncertainties. The intro­
duction of REACH does not change the fact 
that the regulatory system (including the clas­
sification and labeling criteria in EEC 1967) 
does not distinguish between a substance that 
has been tested with negative outcome (no 
harmful effect detected) and a substance that 
has not been tested at all. In both these cases, 
the substance will be treated as having low or 
no toxicity. This is a risk­prone way of manag­
ing chemicals that needs to be replaced by a sys­
tem of risk management that takes into account 
not only known harmful effects but also uncer­
tainties. The classification and labeling system 
should be modified to include reports of lack of 
data. We propose the introduction of a labeling 
symbol to be used when basic toxicity informa­
tion about a substance is lacking (Hansson and 
Rudén 2003). Significant improvements in the 
reporting of uncertainties are also needed in 
safety data sheets.
f) Develop rules for chemicals in articles. 
Although REACH focuses on chemical sub­
stances and products, significant exposures of 
both humans and the environment are medi­
ated by items that include or have been treated 
with chemicals. To take just one example, we 
are exposed to brominated flame retardants 
through electronic devices, furniture, build­
ing materials, and so on, rather than through 
chemical products. Tracing chemical sub­
stances in articles such as these is admittedly a 
much larger undertaking than that of keeping 
track of the contents of chemical products. 
Probably, a less comprehensive system will 
have to be chosen for articles than for chemical 
products. Nevertheless, a strategy for the risk 
management of chemicals is severely incom­
plete unless it tackles the distribution of harm­
ful substances through the wide varieties of 
products in which they are used.
In this commentary we have shown 
that the outcome of the testing required in 
REACH is more uncertain than what may be 
generally realized. Important decisions remain 
to be made, particularly on triggers for testing 
of low­volume substances and on practices 
concerning the waiving of testing for sub­
stances in the high tonnage bands. The aim of 
REACH is to “ensure a high level of protec­
tion of human health and the environment.” 
With this commentary we hope to contribute 
to a scientific discussion about these open 
issues for the future development of REACH.
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